Ian Wilson, the Hansen Professor of Structural Biology and a member of the Skaggs Institute for Chemical Biology at Scripps Research
Colorized negative stained transmission electron micrograph (TEM) depicting some of the ultrastructural morphology of the A/CA/4/09 swine flu virus
Every year in the lead up to flu season, those at high risk of infection, such as the young, the elderly and those who are immune-compromised, head off to the doctor for a jab in the hopes it will protect them from the flu. However, influenza vaccines have a number of shortcomings that means even those who have been vaccinated may still get influenza. Researchers at the Scripps Research Institute and Dutch biopharmaceutical company Crucell have now found a broadly acting antibody that could lead to a single, near-universal flu vaccine to replace annually changing vaccines.
Other Images from this Gallery